Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of EGFR mutations in lung sarcomatoid carcinoma

22 Mar 2010

Abstract excerpt

Around the time when the short report “EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: Implications for anti-EGFR treatment of a rare lung malignancy” was published in the June 2 2009 issue of International Journal of Cancer,1 we had found, during our molecular diagnostic routine on lung neoplasms, a case of primary sarcomatoid lung carcinoma that harbored an exon 19 deletion of the EGF...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Diagnosis and Treatment
Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Metastasis and carcinoma case studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20309946
DOI: 10.1002/ijc.25335

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of EGFR mutations in lung sarcomatoid carcinomaPMID 20309946Read ↗

EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy.Semantic proximity Read ↗

Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases.Semantic proximity Read ↗

Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.Semantic proximity Read ↗

EGFR and p53 status of pulmonary pleomorphic carcinoma: implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy.Semantic proximity Read ↗

Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: Rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistrySemantic proximity Read ↗

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.Semantic proximity Read ↗

Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy.Semantic proximity Read ↗

Concurrent epidermal growth factor receptor T790M secondary mutation and epithelial-mesenchymal transition in a lung adenocarcinoma patient with EGFR-TKI drug resistance.Semantic proximity Read ↗

Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis.Semantic proximity Read ↗

Clinical significance of BRAF gene mutations in patients with non-small cell lung cancer.Semantic proximity Read ↗

A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and ImmunohistochemistrySemantic proximity Read ↗

EGFR mutation-specific antibodies in pulmonary adenocarcinoma: a comparison with DNA direct sequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.